Patent · US Expired

Vaccine

US5786189A · kind A · utility

59Cited by

10References

31Claims

0Family size

Assignee

SmithKline Beecham Biologicals S.A. · BE

Inventors

Camille Locht · Wannehain, FR
Yves Lobet · Rixensart, BE

Key dates

Filing date	Dec 11, 1996
Grant date	Jul 28, 1998
Priority date	—
Expiry date	Dec 11, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K39/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The Bordetella pertussis toxin is genetically modified to express a toxin protein which is deficient in target-cell receptor binding and is used in a vaccine for protection against whooping cough.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.